Creating a tissue biobank for kidney disease research
Michigan Nephrology Research BioBank for Molecular Analysis of Renal Disease "Nephrology Research BioBank"
University of Michigan · NCT00381121
This study is collecting kidney tissue samples from people getting biopsies to see if it can help researchers learn more about chronic kidney disease and find better ways to prevent and treat it.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 420 (estimated) |
| Sex | All |
| Sponsor | University of Michigan (other) |
| Locations | 1 site (Ann Arbor, Michigan) |
| Trial ID | NCT00381121 on ClinicalTrials.gov |
What this trial studies
This study aims to establish a Nephrology Tissue Biobank to facilitate research on chronic kidney disease (CKD) through the lenses of epidemiology, genetics, and molecular biology. By collecting kidney tissue samples from individuals undergoing biopsies, the study will enable researchers to investigate molecular markers and pathways associated with kidney disease and its progression. The ultimate goal is to enhance understanding of kidney health issues and develop new prevention and treatment strategies that can be shared with the medical community and the public.
Who should consider this trial
Good fit: Ideal candidates include men, women, and children undergoing kidney and/or pancreas biopsy at the University of Michigan.
Not a fit: Patients who are not willing to provide consent for prospective biopsy will not benefit from this study.
Why it matters
Potential benefit: If successful, this biobank could lead to improved prevention and treatment strategies for chronic kidney disease.
How similar studies have performed: Other studies utilizing tissue biobanks for chronic diseases have shown promise in advancing understanding and treatment, indicating a potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Men, women and children undergoing kidney and/or pancreas biopsy at the University of Michigan Exclusion Criteria: * Individuals not willing to provide consent (for prospective biopsy)
Where this trial is running
Ann Arbor, Michigan
- University of Michigan Health System — Ann Arbor, Michigan, United States (RECRUITING)
Study contacts
- Principal investigator: Matthias Kretzler,, MD — University of Michigan
- Study coordinator: Chrysta Lienczewsky
- Email: boridley@med.umich.edu
- Phone: 734-764-2924
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Chronic Kidney Disease, Tissue Biobank, molecular markers, molecular pathways